pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-938 |
Genomic Coordinates | chr10: 29602264 - 29602346 |
Synonyms | MIRN938, hsa-mir-938, MIR938 |
Description | Homo sapiens miR-938 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-938 | |||||||||||||||||||||||||||
Sequence | 15| UGCCCUUAAAGGUGAACCCAGU |36 | |||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||
Experiments | Cloned | DRVs in miRNA |
|
|||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | KCTD10 | ||||||||||||||||||||
Synonyms | BTBD28, MSTP028, ULRO61, hBACURD3 | ||||||||||||||||||||
Description | potassium channel tetramerization domain containing 10 | ||||||||||||||||||||
Transcript | NM_031954 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on KCTD10 | |||||||||||||||||||||
3'UTR of KCTD10 (miRNA target sites are highlighted) |
>KCTD10|NM_031954|3'UTR 1 GCAGGCAAGAGACCGAGCCGCCCTCCTCTCACCGCCCCCACTCCCTGCCGTGCTACACCCAGATCCTGTGCAGGCTGCCG 81 GGCCCCTTCTGCTTCCCTTGGAGCCTGGAGATACTTTTGTAACAAGCCAGATGATTATTTTGGTATTGCTTGACAAGGCA 161 AATTGATTGTCTTGACCCAGGCGTATGACCCCTGTCGTTGAACAAGCTGTGTCTAAGATCTCTACTTTTCATGAGAATCT 241 GAGACTCTTTGGAGCCAGGCTTTCTCGGTTCTCAGAGGAAAAGTATGAATGAGTGTGAAGTGTATGTGAGAACTTTTGTT 321 TGCAATATTTATTTTTGTGGGTGTCGACTTCCTATGTGGGCTTTTTGGGTGACACTCCCTTAAGGGTTCAGTTTGACAAT 401 TCTGAGAGTTGTCCTGCAGTTGGAGGCCACCAGAGGTATCTGAGCTCCCTGCTTCCTATTTCATAATCCTCCAGCCCCAG 481 CAGGTCCACTCCTGGTTCCTGTGTGTTTGGCCCGGGCACAATCCCCACTGCTTTGCTAGACGTGCTTTCTGCCATGTGGC 561 TTTGGGCCTAGAGCTTGTTGATAATTGCAGCTTGTGGCAGTGGAAATATGGCTGAATGAGCGTCTAAATCGTTGAGACCA 641 GTGCAACTTTGGGTGCAAGGCTTTGTTTAGGGATCAAGCCTTTTGCCACCTTGGGCTGGTCTTTGGCCTGGTGCTCACTG 721 GGACCCCATATGTCTGCGTAGGAGCAGAACTTTCCATGGCAGTAAGTGTCCAGCTCTGTTTCTGGTTCTTTCCCCAACTC 801 CAGCCCCGTCCAGTTGTTCTCCTGATTGACCCGACTCCACTCCAGGAAGGCCATCTGACCCTGTGACAGGCATAGCTCAT 881 AAACTACCCCTCCCTGGGATCCCGCTCCTCTTCAGCCTCCTTCCCCATGAAGCTGGGCTAACTTTCTAAGTCATTTTGCT 961 TAGAAATTCAGTGTGGCCCATACCCTTTGTCCTCCCAGCCTGGCATCCAGGCAGGGACACCCTCACACCACCAGCCCCAG 1041 GGAGCTTCCCTGCTATAAACACAGACCCCCTTGTCTTTGCCTCTGATTTTTACACAGTGTAGAGTGGCCAGCAGTGAACA 1121 GGTTGAGGATGTGCGGGTAGATAGATAACTTTGGGTCTGGTTTGTGTCTGTGTTCATGTTTGTTTAAGGGATATGTGTGA 1201 CTGTGGGTGGGGACGTGTGCTTGTGGGGCACAGGTGGCGGCCCCTGCTGGAGCCCGGCTGGGCGCAGCGCCTATGTAGGA 1281 CGGGTGTTCTCAGTGACCTACCTCCCAGGCTCCTCTGCACCTGCAAAGGAACAGGAGTGAGTCGTGACTGACAGGGGTGG 1361 TTGAGACTAGACTAGGTAGAGTAGTTACCAGGAGATGTGAATGTGCGTCAGGTGATGGATGGGTTTGTCAAGGGAATCGT 1441 TACCGTTTTATACCAAAGGTATTAACATGGGCAGCCTTTGACACATGTATTCCAAAAACGAGTTTATATTTTCAAACGGT 1521 TTTTACAGCTTAGACTTTGTACTTACTGCCCTGCCTGTGACAGTTGTATGCCTTCATTTTGTATCCAACAGCAAAGTCTA 1601 CAATAAAACTTTAAAACAATCATGACTGAATGTCAAAATCGTGTATTGGGCAGATGCTTTTTAAACTGTCGTGTGAGAAA 1681 CTTTTATATTAGGCCATTTGGATTTTATTAAGTGCTAAGGAAAGAGGGCTTACAAAATGTTTCGTAAATATTTTATACTG 1761 TTTAAGTGTTAAACACCAACCCTGTCTTTCTTTTGGGTTGAGCTTTTTTAGAAAGTCGAAGTGAATGTTGGCCAGGAAAA 1841 TGGAAAAGCCATTGTATAAATTTTTTTTTGAGGCGGAGTCTTGCTCTATTGGCCAGGCTGGAGTGTAGTGGCACCATCTC 1921 CACTTACCACAACTTGTGCCTCCTGGGTTCAAGCGATTCTGCTGCCTCAGCCTCCCGAGTAGCTGGGATTGCAGGTACCC 2001 ATCAGCCCATGCCCAGCTAATTTTGTATTTTTAGTAGAGATGGGGTTTCACCATGTTGGCCAGGCTGGTCTTGAACTCCT 2081 GACCCTGTGATCCGACCACCTTGGCCTCCCAAAGTGCTGGGATTACAGGTGTGAGTCACCACACCTGGCTGCATAGTGTT 2161 TTAAATGTTTGTGTGAAGAATGAGTTTGTGGAACAATTTGATTTGCTGTGGCCTCTATGCCTAATGAGCTAGTGTTTCTG 2241 GCAGCTCTCTCTACCCAACTTTGCACTTGTAGTTTTGAGTCTTTGTCTCTCTGGAATATGAACAGGTTTATAAAACATTC 2321 CATGGTGAACAATTCTGTCGGCTGCATTATAGCCATGAGTGAATAGACAGCATTGGCTGGTCCAAGCTCTGTTATTGAGT 2401 ATACAAGGAACTGATTTTTCTTATGTTAGCACTAAGGGCAAAAACCAATATTTATAATGTAAGCACTATCCAGGTAAAAC 2481 ACTGGCCCAAGATTTGGTAAAGAGATTTCATTGCAATGTAATAACTACAGTTTTTTACAAATTGGAACAGCTTTGGTGTG 2561 TCGTAATCAAGGGTTTTTTTTGTTTGTTTGTTTCAAATAAGCCATCTGATTGTGGTGACTGGGGCCCATGTCCAAGACAA 2641 TTCCTGGCATATTCTGTCACCCTCCCGTGGGGCGATCACTGTGTGGGGACCCCATTCCCCAGTTAAAGTGTGTCTCTGTA 2721 CCTTACAACAGCGATTCAGGACCCAAGTGTGAACAACACTCAGCCCGCCCTCTGGAGCGTGTGCTGTCTTTAGGGCCCTA 2801 CCCAAAGTCACTGTAACAGTTAAGTGTGTCATTAACCTTTCTGTCTCTTTGCGCCATAAAAAAATGCTCAAAGTTTTAGA 2881 TGTAGCCACTGTATGTTGTACAAACGTTGGCGACATGTAAAATAAAAGTCATAAAATGCTAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | hESCs (WA-09) |
Disease | 83892.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine
... - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development. |
Article |
- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al. - Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
|
CLIP-seq Support 1 for dataset SRR359787 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | hESCs (WA-09) / 4-thiouridine, RNase T1 |
Location of target site | ENST00000228495.6 | 3UTR | AUUUUUCUUAUGUUAGCACUAAGGGCAAAAACCAAUAUUUAUAAUGUAAGCACUAUCCAGG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22012620 / SRX103431 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
54 hsa-miR-938 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT073757 | NUBP1 | nucleotide binding protein 1 | 2 | 2 | ||||||||
MIRT092006 | SNRK | SNF related kinase | 2 | 12 | ||||||||
MIRT218174 | MRPL18 | mitochondrial ribosomal protein L18 | 2 | 2 | ||||||||
MIRT485452 | IVNS1ABP | influenza virus NS1A binding protein | 2 | 2 | ||||||||
MIRT489857 | ATP2A3 | ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 | 2 | 2 | ||||||||
MIRT495407 | SPPL3 | signal peptide peptidase like 3 | 2 | 4 | ||||||||
MIRT495762 | ZNF607 | zinc finger protein 607 | 2 | 2 | ||||||||
MIRT497391 | RALY | RALY heterogeneous nuclear ribonucleoprotein | 2 | 2 | ||||||||
MIRT499227 | VAV3 | vav guanine nucleotide exchange factor 3 | 2 | 4 | ||||||||
MIRT507059 | H3F3B | H3 histone family member 3B | 2 | 2 | ||||||||
MIRT513671 | SOCS5 | suppressor of cytokine signaling 5 | 2 | 8 | ||||||||
MIRT526922 | IRGQ | immunity related GTPase Q | 2 | 4 | ||||||||
MIRT527488 | OCIAD1 | OCIA domain containing 1 | 2 | 2 | ||||||||
MIRT527566 | ADCY7 | adenylate cyclase 7 | 2 | 2 | ||||||||
MIRT528081 | NOL9 | nucleolar protein 9 | 2 | 2 | ||||||||
MIRT528535 | CYP2C19 | cytochrome P450 family 2 subfamily C member 19 | 2 | 4 | ||||||||
MIRT533896 | TBL1XR1 | transducin beta like 1 X-linked receptor 1 | 2 | 2 | ||||||||
MIRT536523 | KCTD10 | potassium channel tetramerization domain containing 10 | 2 | 2 | ||||||||
MIRT541382 | CDKN1A | cyclin dependent kinase inhibitor 1A | 2 | 2 | ||||||||
MIRT550254 | FAM120AOS | family with sequence similarity 120A opposite strand | 2 | 2 | ||||||||
MIRT555975 | NPTN | neuroplastin | 2 | 2 | ||||||||
MIRT557394 | H3F3C | H3 histone family member 3C | 2 | 2 | ||||||||
MIRT568594 | ADM | adrenomedullin | 2 | 2 | ||||||||
MIRT571876 | NCL | nucleolin | 2 | 2 | ||||||||
MIRT572443 | TRIM10 | tripartite motif containing 10 | 2 | 2 | ||||||||
MIRT610589 | PRDM1 | PR/SET domain 1 | 2 | 2 | ||||||||
MIRT614044 | THBS2 | thrombospondin 2 | 2 | 2 | ||||||||
MIRT618412 | ATP2A2 | ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 | 2 | 2 | ||||||||
MIRT623398 | LHFPL2 | LHFPL tetraspan subfamily member 2 | 2 | 2 | ||||||||
MIRT623948 | FBXO47 | F-box protein 47 | 2 | 2 | ||||||||
MIRT625349 | MGLL | monoglyceride lipase | 2 | 2 | ||||||||
MIRT635447 | FAM180B | family with sequence similarity 180 member B | 2 | 2 | ||||||||
MIRT638249 | SLC16A9 | solute carrier family 16 member 9 | 2 | 2 | ||||||||
MIRT642662 | RGS6 | regulator of G protein signaling 6 | 2 | 2 | ||||||||
MIRT646431 | ARAP1 | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 | 2 | 2 | ||||||||
MIRT647172 | ARGFX | arginine-fifty homeobox | 2 | 2 | ||||||||
MIRT654891 | POU2F1 | POU class 2 homeobox 1 | 2 | 2 | ||||||||
MIRT659337 | CSE1L | chromosome segregation 1 like | 2 | 2 | ||||||||
MIRT667407 | MGAT5 | mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase | 2 | 2 | ||||||||
MIRT698892 | SPTBN2 | spectrin beta, non-erythrocytic 2 | 2 | 2 | ||||||||
MIRT703841 | ETV3 | ETS variant 3 | 2 | 2 | ||||||||
MIRT708322 | NT5C | 5', 3'-nucleotidase, cytosolic | 2 | 2 | ||||||||
MIRT708934 | CRY2 | cryptochrome circadian clock 2 | 2 | 2 | ||||||||
MIRT709745 | UBD | ubiquitin D | 2 | 2 | ||||||||
MIRT710265 | FAM107A | family with sequence similarity 107 member A | 2 | 2 | ||||||||
MIRT712576 | ATP2B4 | ATPase plasma membrane Ca2+ transporting 4 | 2 | 2 | ||||||||
MIRT712645 | TXNL4A | thioredoxin like 4A | 2 | 2 | ||||||||
MIRT714833 | SCAMP2 | secretory carrier membrane protein 2 | 2 | 2 | ||||||||
MIRT720673 | SLC39A13 | solute carrier family 39 member 13 | 2 | 2 | ||||||||
MIRT723041 | MAPT | microtubule associated protein tau | 2 | 2 | ||||||||
MIRT723669 | CTC1 | CST telomere replication complex component 1 | 2 | 2 | ||||||||
MIRT723772 | ROBO4 | roundabout guidance receptor 4 | 2 | 2 | ||||||||
MIRT723812 | OR1L8 | olfactory receptor family 1 subfamily L member 8 | 2 | 2 | ||||||||
MIRT736795 | RBM5 | RNA binding motif protein 5 | 2 | 0 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|